Antibacterial Spiropyrimidinetriones with N‑Linked Azole Substituents on a Benzisoxazole Scaffold Targeting DNA Gyrase
datasetposted on 02.10.2020 by Gregory S. Basarab, Peter Doig, Charles J. Eyermann, Vincent Galullo, Gunther Kern, Amy Kimzey, Amy Kutschke, Marshall Morningstar, Virna Schuck, Karthick Vishwanathan, Fei Zhou, Madhusudhan Gowravaram, Sheila Hauck
Datasets usually provide raw data for analysis. This raw data often comes in spreadsheet form, but can be any collection of data, on which analysis can be performed.
Herein, we report spiropyrimidinetriones (SPTs) incorporating N-linked azole substituents on a benzisoxazole scaffold with improved Gram-positive antibacterial activity relative to previously described analogues. SPTs have an unusual spirocyclic architecture and represent a new antibacterial class of bacterial DNA gyrase and topoisomerase IV inhibitors. They are not cross-resistant to fluoroquinolones and other DNA gyrase/topoisomerase IV inhibitors used clinically. The activity of the SPTs was assessed for DNA gyrase inhibition, and the antibacterial activity across Gram-positive and Gram-negative pathogens with N-linked 1,2,4-triazoles substituted on the 5-position provides the most worthwhile profile. Directed nucleophilic and electrophilic chemistry was developed to vary this 5-position with carbon, nitrogen, or oxygen substituents and explore structure–activity relationships including those around a target binding model. Compounds with favorable pharmacokinetic parameters were identified, and two compounds demonstrated cidality in a mouse model of Staphylococcus aureus infection.